The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

Researchers provide essential insights on the molecular activation of the MAP kinase p38?, the final switch triggering the inflammatory response. Inflammation is a cellular coping mechanism when ...

Australian company OmnigeniQ has revealed the first computer model of a human protein as it exists in the body, confirming that native protein ...